Skip to main content

Advertisement

Log in

DOCK2 Deficiency Diagnosed 18 Years After Hematopoietic Stem Cell Transplantation

  • Letter to Editor
  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Alizadeh Z, Mazinani M, Shakerian L, Nabavi M, Fazlollahi MR. DOCK2 deficiency in a patient with hyper IgM phenotype. J Clin Immunol. 2018;38:10–2.

    Article  CAS  Google Scholar 

  2. Alosaimi MF, Shendi H, Beano A, Stafstrom K, El Hawary R, Meshaal S, et al. T-cell mitochondrial dysfunction and lymphopenia in DOCK2-deficient patients. J Allergy Clin Immunol. 2019;144(306–9):e2.

    Google Scholar 

  3. Moens L, Gouwy M, Bosch B, Pastukhov O, Nieto-Patlan A, Siler U, et al. Human DOCK2 deficiency: report of a novel mutation and evidence for neutrophil dysfunction. J Clin Immunol. 2019;39:298–308.

    Article  CAS  Google Scholar 

  4. Dobbs K, Dominguez Conde C, Zhang SY, Parolini S, Audry M, Chou J, et al. Inherited DOCK2 deficiency in patients with early-onset invasive infections. N Engl J Med. 2015;372:2409–22.

    Article  CAS  Google Scholar 

  5. Guo X, Shi N, Cui XB, Wang JN, Fukui Y, Chen SY. Dedicator of cytokinesis 2, a novel regulator for smooth muscle phenotypic modulation and vascular remodeling. Circ Res. 2015;116:e71-80.

    Article  CAS  Google Scholar 

Download references

Funding

This research was in part funded by the IRCM Foundation and the J -Louis Lévesque Foundation.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hugo Chapdelaine.

Ethics declarations

All authors reviewed and agreed with the final manuscript.

Conflict of Interest

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 21 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

D’Astous-Gauthier, K., Desjardins, A., Marois, L. et al. DOCK2 Deficiency Diagnosed 18 Years After Hematopoietic Stem Cell Transplantation. J Clin Immunol 41, 1400–1402 (2021). https://doi.org/10.1007/s10875-021-01040-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10875-021-01040-4

Keywords

Navigation